Malignant brain tumors are cancerous growth in the brain with the possibility of spreading to other parts of the central nervous system (CNS). Brain tumors are highly invasive and have devastating consequences, poor prognosis, and low survival rates.
Recently, the noninvasive near-infrared fluorescence and photoacoustic imaging techniques have demonstrated a bright scope in brain tumor diagnosis with high spatiotemporal resolution, large penetration depth, and good sensitivity. Hence, these imaging techniques have been used to guide real-time brain tumor therapy with high efficiency and accuracy.
An article published in the journal Advanced Drug Delivery Reviews presented a summary of state-of-art near-infrared contrast agents (CAs) and optical imaging-guided therapies for brain tumor imaging. Finally, the opportunities and challenges involved in the use of CAs and nanotheranostics for future clinical translation were discussed.
Near-Infrared Fluorescence Imaging of Brain Tumors
The brain tumor is an intracranial neoplasm in the brain or the central spinal canal. An abnormal and uncontrolled cell division, usually in the brain, involving neurons or glial cells or occasionally in the lymphatic tissue, blood vessels, and others, is the main leading cause of the formation of primary brain tumors. The majority of the brain tumors in adults are secondary or metastatic tumors, that is, cancers primarily located in other organs and may spread to the brain and create brain tumors.
Diagnosis of brain tumors is the critical step for effective curing of the disease, and it vividly relies on the advancements in molecular imaging technology. Although various imaging modalities, including magnetic resonance imaging (MRI), positron emission tomography (PET) imaging, and computed tomography (CT) imaging were investigated for the detection of brain tumors, these modalities possess several limitations.
In this regard, fluorescence imaging is a method that relies on fluorescence, absorption, bioluminescence, and reflectance resulting from various fluorescent nanomaterials used for visualizing the brain microstructures and monitoring the tumor progression.
Nevertheless, the effectiveness and safety of fluorescence imaging, using visible light for fluorescence imaging, displayed limited penetration of the light and resulted in decreased light-tissue interactions. Light in the near-infrared range (wavelength: 650–900 nanometers) has several advantages over visible-range light, including deeper tissue penetration due to less absorption by hemoglobin and water and less autofluorescence from surrounding tissues. Consequently, a new scope has emerged for near-infrared fluorescence imaging for detecting and treating brain tumors.
Near-infrared fluorescence imaging of brain tumors is a growing field for preclinical and clinical applications in clinical management due to its advantageous features, including a high spatial resolution, portability, real-time display, and detailed molecular profiling with the multiplexed use of fluorescent probes.
Similarly, near-infrared photoacoustic imaging (PAI) is a noninvasive imaging technique that involves acoustic waves as the emission source. It combines the advantages of ultrasonic and optical energies to realize biological imaging with deep tissue penetration depth. Thus, making PAI a promising diagnosis technique.
Near Infrared Optical Imaging-Guided Treatment of Brain Tumors
Near-infrared optical imaging-guided brain tumor therapy has been used in theranostics. Various therapeutic functions have been demonstrated with the assistance of near-infrared fluorescence imaging and PAI.
Despite encouraging progress, several obstacles remain in transitioning optical imaging techniques to clinical applications. As safety is the primary concern for the clinical translation of nanomedicine, nanotheranostics and nanoprobes are subjected to various surface modifications using biocompatible polymers to reduce their toxicities.
Near-infrared fluorescence imaging and PAI have vividly helped in the diagnosis of cancer. However, the presence of the skull and scalp hampers the quality of light and the imaging of brain tumors. This suggests that the second near-infrared region (NIR-II) can increase tissue penetration and depth while decreasing light scattering and enhancing the signal-to-background ratio. Consequently, deep-seated brain tumors can also be diagnosed.
CAs with excited-state intramolecular motion have good prospects for fine-tuning the balance between nonradiative and radiative decay in dual-mode near-infrared fluorescence imaging or PAI. Near-infrared fluorescence imaging CAs, including organic dyes, semiconducting polymer dots, aggregation-induced emission luminous, and inorganic (quantum dots and rare-earth nanoparticles) probes, have been investigated for the diagnosis of brain tumors.
Conclusion
Overall, multimodal optical imaging techniques can decrease misdiagnosis rates of brain tumors and provide functional and anatomical information. Moreover, theranostic agent-based imaging guidance and combination treatment can enhance the treatment outcomes of brain tumors and reduce side effects.
Furthermore, nanoparticles less than 5 nanometers in size are favorable for renal excretion and reduce toxicity during treatment. Thus, the fabrication of biodegradable nanomaterials followed by toxicity evaluations can increase the clinical success of treatment.
In the case of brain tumors, the blood-brain barrier restricts the entry of nanoagents into brain tissues. In this regard, peptides with targeting abilities and focused ultrasound (FUS) assistance can help deliver nanoagents to brain tumors for diagnosis and therapy.
News – Curated by Amanda Scott
Scientists Use Exotic DNA To Help Create “Climate-Proof” Crops
The incorporation of exotic DNA from wild relatives into wheat results in a remarkable yield increase of up to 50%, even in hot weather, surpassing elite lines without these genes. Amid a year of [...]
Australia becomes first country to recognise psychedelics as medicines
Australia has become the first country to recognise psychedelics as medicines, after the Therapeutic Goods Administration took researchers by surprise and approved the psychedelic substances in magic mushrooms and MDMA for use by people [...]
Silver nanoparticles show promise in fighting antibiotic-resistant bacteria
In a new study, scientists with the University of Florida have found that a combination of silver nanoparticles and antibiotics is effective against antibiotic-resistant bacteria. The researchers hope to turn this discovery into viable [...]
Combating severe cancer with a new drug delivery system
Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with [...]
New Research Shows How Ketamine Acts As “Switch” in the Brain
According to a new study by researchers at Penn Medicine, ketamine, which is well-known as an anesthetic and is becoming increasingly popular as an antidepressant, dramatically reorganizes activity in the brain, almost as if [...]
Supercharged T Cells: A New Way To Kill Pancreatic Cancer With Minimal Side Effects
A new immunotherapy releases cancer-killing cytokines only within the tumor. Researchers at the University of California San Francisco (UCSF) have developed a new T cell-based immunotherapy that selectively targets cancer cells, producing a powerful anti-cancer cytokine [...]
AI has designed bacteria-killing proteins from scratch – and they work
An AI was tasked with creating proteins with anti-microbial properties. Researchers then created a subset of the proteins and found some did the job. An AI has designed anti-microbial proteins that were then tested [...]
Using nanoparticles, researchers can identify and deliver synergistic combinations of cancer drugs
Treating cancer with combinations of drugs can be more effective than using a single drug. However, figuring out the optimal combination of drugs, and making sure that all of the drugs reach the right [...]
Humanity May Reach Singularity Within Just 7 Years, Trend Shows
By one unique metric, we could approach technological singularity by the end of this decade, if not sooner. A translation company developed a metric, Time to Edit (TTE), to calculate the time it takes for professional [...]
HYPER (Highly Interactive Particle Relics) – A New Model for Dark Matter
Phase transition in early universe changes strength of interaction between dark and normal matter. Dark matter remains one of the greatest mysteries of modern physics. It is clear that it must exist, because without [...]
New Nanoparticles Deliver Therapy Brain-Wide and Edit Alzheimer’s Gene
Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of [...]
Cancer’s Secret Weapon? Enzyme That Protects Against Viruses May Fuel Tumor Evolution
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The [...]
Scientists Uncover Japanese Fruit Juice That May Help Prevent Lung Cancer
Using a mouse model, Japanese researchers unleash the likely mechanism of action of Actinidia arguta (sarunashi) juice on lung cancer development. Lung cancer is a leading cause of death in Japan and across the [...]
In-place manufacturing method improves gas sensor capabilities, production time
When used as wearable medical devices, stretchy, flexible gas sensors can identify health conditions or issues by detecting oxygen or carbon dioxide levels in the breath or sweat. They also are useful for monitoring [...]
In the core of the cell: New insights into the utilization of nanotechnology-based drugs
Novel drugs, such as vaccines against covid-19, among others, are based on drug transport using nanoparticles. Whether this drug transport is negatively influenced by an accumulation of blood proteins on the nanoparticle’s surface was [...]
The costly lesson from COVID: why elimination should be the default global strategy for future pandemics
Imagine it is 2030. Doctors in a regional hospital in country X note an expanding cluster of individuals with severe respiratory disease. Rapid whole-genome sequencing identifies the disease-causing agent as a novel coronavirus. Epidemiological [...]
